A roadmap for improving representation in clinical trials
Clinical trials continue to struggle with recruiting diverse participants that include historically underrepresented and minoritized patients, who are typically patients in non-white racial and ethnic groups and have low income (Medicaid). Enrolling diverse participants will benefit the health scien...
Saved in:
| Main Authors: | Amanda F. Petrik, Nora B. Henrikson, Gloria D. Coronado, Erin Keast, Matthew P. Banegas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Contemporary Clinical Trials Communications |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2451865424001212 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial
by: Carrie M. Nielson, et al.
Published: (2018-09-01) -
SOVEREIGNTY, DIPLOMACY AND DEMOCRACY: THE CHANGING CHARACTER OF “INTERNATIONAL REPRESENTATION” — FROM STATE TO SELF
by: Alan K. Henrikson
Published: (2015-07-01) -
An open source pharma roadmap.
by: Manica Balasegaram, et al.
Published: (2017-04-01) -
Embedding Safe System in Victoria: Blockers, Enablers and Improvement Roadmap
by: Hafez Alavi, et al.
Published: (2023-05-01) -
Roadmapping in Developing Countries
by: Anthony Clayton
Published: (2009-03-01)